A Dose-Finding Study of E7389 in Combination With Carboplatin in Patients With Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2005-12-23
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT00268905
A Study of Amolimogene (ZYC101a) in Patients With High Grade Cervical Intraepithelial Lesions of the Uterine Cervix
- First Posted Date
- 2005-12-13
- Last Posted Date
- 2013-05-29
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 251
- Registration Number
- NCT00264732
- Locations
- 🇺🇸
Physician Care Clinical Research, Sarasota, Florida, United States
🇺🇸University of Arizona, Tucson, Arizona, United States
🇺🇸Visions Clinical Research, Boynton Beach, Florida, United States
An Effectiveness and Safety Study of AQUAVAN® Injection (Fospropofol Disodium) for Sedation During Colonoscopy
- Conditions
- First Posted Date
- 2005-12-05
- Last Posted Date
- 2008-11-07
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT00261599
- Locations
- 🇺🇸
Oakland Colon & Rectal Associates, Royal Oak, Michigan, United States
🇺🇸Indiana University Medical Center/Clarian Health Partner, Indianapolis, Indiana, United States
🇺🇸Alamo Research Center, San Antonio, Texas, United States
Trial of Decitabine in Patients With Acute Myeloid Leukemia
- Conditions
- Interventions
- First Posted Date
- 2005-12-02
- Last Posted Date
- 2019-09-11
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 485
- Registration Number
- NCT00260832
A Study of Decitabine Given to Adults With Advanced-Stage Myelodysplastic Syndromes
- First Posted Date
- 2005-12-01
- Last Posted Date
- 2013-05-20
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 99
- Registration Number
- NCT00260065
A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine
- First Posted Date
- 2005-10-30
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 298
- Registration Number
- NCT00246090
- Locations
- 🇺🇸
Peachtree Hematology And Oncology Consultants, Atlanta, Georgia, United States
🇺🇸Central Indiana Cancer Center, Indianapolis, Indiana, United States
🇺🇸Texas Oncology PA, Houston, Texas, United States
E3810-A001-313: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2010-04-06
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 629
- Registration Number
- NCT00236184
- Locations
- 🇺🇸
Jeffrey L. Newman, Vista, California, United States
E3810-A001-312: Efficacy and Safety of 10 mg Rabeprazole for Treating Heartburn in Frequent Sufferers
- First Posted Date
- 2005-10-12
- Last Posted Date
- 2009-11-11
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 619
- Registration Number
- NCT00236197
- Locations
- 🇺🇸
New York Center For Clinical Research, Lake Success, New York, United States
EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)
- Conditions
- First Posted Date
- 2005-10-03
- Last Posted Date
- 2011-04-01
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT00230568
- Locations
- 🇺🇸
Clinical Research Center, Jenkintown, Pennsylvania, United States
🇺🇸University of New Mexico School of Medicine, Department of Psychiatry, Albuquerque, New Mexico, United States
🇺🇸21st Century Neurology, Phoenix, Arizona, United States
A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Patients Undergoing Elective Colonoscopy
- Conditions
- First Posted Date
- 2005-09-21
- Last Posted Date
- 2008-11-07
- Lead Sponsor
- Eisai Inc.
- Target Recruit Count
- 270
- Registration Number
- NCT00209573